Bond University’s already strong teaching contingent - which received five stars in the recent Good Universities Guide for ‘Staff Qualifications’ and ‘Teaching Quality’ - has been further bolstered with the addition of one of the world’s leading stem cell researchers, Professor Patrick Warnke.
Professor Warnke, also a plastic surgeon, joins Bond from Germany’s Kiel University.
He is the co-ordinator of the esteemed MyJoint consortium, a cutting-edge tissue engineering network focused on enabling patients to use their own bodies as ‘bio-reactors’ to grow replacement bones and organs.
In a great achievement for Bond’s Health Sciences and Medicine Faculty, Professor Warnke will involve the University in MyJoint’s efforts.
Faculty Dean Professor Chris Del Mar said Professor Warnke’s appointment was a huge coup for Bond.
“Professor Warnke is at the forefront of adult stem cell research and to have these sorts of minds at Bond is a great win for students and staff,’’ said Professor Del Mar.
“The opportunity for Bond to contribute to MyJoint heralds a very exciting time for research at the University.’’
Professor Warnke, who has arrived in Australia on a four-year term, was extremely excited by Bond’s involvement in the project.
“We are going to be taking some wrong turns in our research, but if we can find the break-through, people will have the benefit of natural replacement joints or organs, made from their own cells, instead of having artificial ones or waiting for donors,’’ he said.
Professor Warnke gained international prominence after leading a research team that grew a new jaw bone for a cancer sufferer by grafting bone marrow cells from the patient onto a mesh mould inserted in their back. Over time the jaw bone grew with the patient acting as a ‘human bioreactor’.
This month, Professor Warnke and his fellow team of surgeons were highlighted in the New York Times for their latest study on essential oils against MRSA (methicillin-resistant Staphylococcus aureus), a bacterial infection that is highly resistant to some antibiotics.
Professor Warnke is part of a string of major appointments to Bond’s Faculty of Health Sciences and Medicine in the last 12 months including Oxford University’s evidence-based practice specialist Professor Paul Glasziou and incoming faculty Dean Professor Richard Hays from the UK’s Keele University.